Germany
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.38 B
|
Dec. 31, 2023 | USD 123.08 | 5.04% |
|
Germany |
|
2 |
USD 217.22 M
|
Dec. 31, 2023 | USD 42.86 | 0.25% |
|
Germany |
|
3 |
USD 43.61 M
|
Dec. 31, 2023 | USD 3.80 | 5.15% |
|
Germany |
|
4 |
USD 31.24 M
|
Dec. 31, 2023 | USD 55.66 | 3.14% |
|
Germany |
|
5 |
USD 6.90 M
|
Dec. 31, 2023 | USD 1.44 | 1.72% |
|
Germany |
|
6 |
USD 4.18 M
|
Dec. 31, 2023 | USD 2.41 | 1.69% |
|
Germany |
|
7 |
USD 1.07 M
|
Nov. 30, 2023 | USD 2.56 | 1.91% |
|
Germany |
|
8 |
USD 565.12 K
|
Dec. 31, 2023 | USD 2.04 | 1.81% |
|
Germany |
|
9 |
USD 459.16 K
|
Dec. 31, 2023 | USD 1.71 | -2.14% |
|
Germany |
The Vaccines company in Germany with the highest Receivables is BioNTech SE (Frankfurt Stock Exchange: 22UA.F) at USD 2.38 B.
The Vaccines company in Germany with the lowest Receivables is Medigene AG (XETRA: MDG1.DE) at USD 459.16 K.
The top 10 Vaccines companies in Germany by Receivables are BioNTech SE, Biotest AG, CureVac N.V., Formycon AG, NanoRepro AG, InflaRx N.V., Heidelberg Pharma AG, Vivoryon Therapeutics N.V. and Medigene AG.
The bottom 10 Vaccines companies in Germany by Receivables are Medigene AG, Vivoryon Therapeutics N.V., Heidelberg Pharma AG, InflaRx N.V., NanoRepro AG, Formycon AG, CureVac N.V., Biotest AG and BioNTech SE.